Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination
Orbital Tumor in a 62-year-old Patient
September-October 2023, Volume 20, Issue 5

Orbital Tumor in a 62-year-old Patient

Edwin Uriel Suárez M., MD,1 Daniel Morillo  Giles, MD,and Miguel Ángel Piris, MD, PhD2
1. Department of Hematology, Hospital Universitario Fundación Jiménez Diaz Madrid, Spain
2. Department of Pathology, Hospital Universitario Fundación Jiménez Diaz Madrid, Spain
Published on: August 31, 2023

A 62-year-old man presented with progressive ptosis of the left eyelid, which he had been experiencing for the past year. He had no other symptoms or significant medical history. Physical examination revealed a firm mass below the left supraorbital rim, with secondary mechanical ptosis (Figure 1). Magnetic resonance imaging (MRI) revealed an extraconal, expansile lesion with well-defined edges at the level of the left upper eyelid, along with predominantly hypointense homogeneous signal intensity in T1 and T2 sequences showing restricted diffusion (Figure 2). Analysis of the biopsy specimen revealed a diffuse pattern of small lymphocyte proliferation and monomorphic cytology consisting predominantly of centrocyte-like cells of B-cell lineage (CD20+). Cyclin D1 and SOX11 expression were detected, although the specimen was negative for BCL6, CD5, CD10, and CD23 expression (Figure 3). The neoplastic cells exhibited restricted expression of kappa light chain, an unremarkable pattern of p53 expression (wild-type pattern), and a low Ki67 proliferation index. Fluorescence in situ hybridization detected chromosomal rearrangement involving CCND1 at 11q13.

Figure 1. Mechanical ptosis at the level of the left orbit.


 

Figure 2. Axial MRI showing a lesion in the extraconal compartment of the left orbit.


 

Figure 3. Biopsy findings. A: Magnified image of hematoxylin and eosin (H&E) staining; B: CD20+ staining; C: Reaction of the tumor cells with anti-cyclin D1; D: Low Ki67 index.


 

Drs. Suárez, Morillo, and Piris indicated no relevant conflicts of interest.

 
Close Modal

or Create an Account

Close Modal
Close Modal